Mutua de Terrassa -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2009

  1. Nonpegylated liposomal doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-overexpressing breast cancer: A multicenter phase l/ll study

    Clinical Cancer Research, Vol. 15, Núm. 1, pp. 307-314